What we do
Our research group is focusing on developing novel human monoclonal antibody-based targeted cancer therapeutics. Our strategy is to develop and utilize an antibody library selection approach to functionally probe the internalizing cell surface epitope space associated with living tumor cells residing in their tissue microenvironment, and identify novel antibody-antigen/epitope interactions that can be exploited for therapeutic targeting.